No. | Gender | Age (years) | Cause | Course of disease (Months) | Duration from surgery to leakage (Days) | Fistula type | Size (mm) | Location of fistula | Comorbidities | Pleural effusion | Atelectasis | Stent size × | Complications |
1 | Male | 61 | Esophageal cancer | 1.5 | 9 | Gastroesophageal anastomotic fistula | 2.9 | Lower part | None | A small amount | None | 20 × 120 | Stent migration |
2 | Male | 52 | Esophagogastric carcinoma | 0.6 | 12 | Gastroesophageal anastomotic fistula | 6.5 | Middle part | None | None | None | 20 × 130;20 × 100 | None |
3 | Male | 68 | Esophageal cancer | 0.8 | 6 | Gastroesophageal anastomotic fistula | 7.0 | Middle part | None | A small amount | None | 20 × 70 | Stent migration |
4 | Male | 65 | Carcinoma of gastric cardia | 2.0 | 60 | Gastroesophageal anastomotic fistula | 8.0 | Upper and middle parts | Esophageal stricture+coronary heart disease | None | None | 20 × 120;20 × 120 | Stent restenosis |
5 | Male | 70 | Carcinoma of gastric cardia | 1.0 | 12 | Gastroesophageal anastomotic fistula | 8.4 | Middle part | None | None | None | 20 × 120 | None |
6 | Male | 53 | Carcinoma of gastric cardia | 2.0 | 150 | Gastroesophageal anastomotic fistula | 2.1 | Middle part | Esophageal stricture | A small amount | None | 20 × 120;18 × 160;18 × 120 | Stent restenosis |
7 | Male | 70 | Esophageal cancer | 6.0 | 171 | Gastroesophageal anastomotic fistula | 9.5 | Middle part | Hypetension+Diabetes | None | Mild | 18 × 120 | None |
8 | Male | 63 | Gastric carcinoma | 4.0 | 36 | Anastomotic leak after esophagojejunostomy | 4.8 | Lower part | Esophageal stricture | None | None | 20 × 100;20 × 100 | Stent restenosis |
9 | Male | 50 | Esophagogastric carcinoma | 3.0 | 30 | Gastroesophageal anastomotic fistula | 1.3 | Lower part | Hypetension | A small amount | Moderate | 18 × 100 | None |
10 | Male | 76 | Esophageal cancer | 1.0 | 6 | Gastroesophageal anastomotic fistula | 1.8 | Middle part | Diabetes | None | None | 18 × 120;18 × 120 | Stent migration |
11 | Male | 53 | Gastric carcinoma | 6.0 | 9 | Anastomotic leak after esophagojejunostomy | 5.1 | Lower part | None | None | None | 20 × 100 | None |
12 | Male | 58 | Esophageal cancer | 3.0 | 6 | Gastroesophageal anastomotic fistula | 5.5 | Middle part | None | A small amount | Mild | 18 × 120 | None |
13 | Male | 64 | Carcinoma of gastric cardia | 3.0 | 6 | Anastomotic leak after esophagojejunostomy | 9.6 | Lower part | None | A small amount | Mild | 20 × 100–20 × 40–20 × 40 | None |
14 | Male | 52 | Esophageal perforation | 4.0 | 12 | Gastroesophageal anastomotic fistula | 5.1 | Lower part | None | Medium | Moderate | 20 × 120 | None |
15 | Male | 58 | Esophageal cancer | 0.5 | 9 | Gastroesophageal anastomotic fistula | 8.8 | Upper and middle parts | Diabetes | A small amount | None | 20 × 80 | Stent migration |
16 | Male | 52 | Esophageal cancer | 5.0 | 15 | Gastroesophageal anastomotic fistula | 7.1 | Middle part | None | A small amount | Mild | 18 × 90 | Stent migration |
17 | Male | 60 | Esophageal cancer | 3.0 | 9 | Gastroesophageal anastomotic fistula | 9.3 | Middle part | None | None | None | 18 × 100 | Stent migration |
18 | Female | 51 | Gastric carcinoma | 11.0 | 270 | Anastomotic leak after esophagojejunostomy | 7.6 | Lower part | Esophageal stricture | None | None | 22 × 80–22 × 50–22 × 50 | Failure in stent placement |
19 | Male | 43 | Carcinoma of gastric cardia | 3.0 | 69 | Anastomotic leak after esophagojejunostomy | 6.7 | Lower part | Esophageal stricture | Medium | Moderate | 20 × 120 | Stent migration |
20 | Male | 54 | Esophageal cancer | 1.0 | 210 | Gastroesophageal anastomotic fistula | 7.7 | Middle and lower parts | None | A small amount | None | 18 × 140;20 × 120 | Migration of stent and abscess drainage tube |
21 | Female | 72 | Gastric carcinoma | 0.3 | 6 | Anastomotic leak after esophagojejunostomy | 4.1 | Lower part | None | None | None | 20 × 100 | None |
22 | Male | 65 | Carcinoma of gastric cardia | 1.0 | 15 | Gastroesophageal anastomotic fistula | 5.9 | Lower part | None | A small amount | Mild | 20 × 120 | None |
23 | Female | 65 | Gastric carcinoma | 6.0 | 18 | Anastomotic leak after esophagojejunostomy | 3.8 | Lower part | Diabetes | None | None | 20 × 140 | Stent migration |
24 | Male | 59 | Carcinoma of gastric cardia | 12.0 | 12 | Anastomotic leak after esophagojejunostomy | 5.2 | Lower part | None | Medium | Moderate | 20 × 140 | None |
Adjustment/replacement time of stent | Adjustment/replacement time of abscess drainage tube | Abscess cavity | Removal of stent/abscess drainage tube | Retention of stent (Months) | Retention of drainage tube (Months) | Maximal body temperature (°C) | Leukocytes (×109/L) | Neutrophil (%) | Other interventional treatments | Survival time after procedure (M) | Death cause | ||
1 | 1 | Disappear | Yes | 1.6 | 14.6 | Normal | 7.7 | 72.5 | None | 67.1 | Survive without symptom | ||
1 | 0 | Disappear | Yes | 1.5 | 2.1 | Normal | 4.5 | 64.9 | None | 24.5 | Survive with slight reflux | ||
3 | 2 | Decreased | Yes | 10.5 | 10.6 | 39.0 | 7.4 | 76.3 | None | 19.9 | Survive without symptom | ||
1 | 0 | Decreased | No | 1.8 | 1.4 | 38.5 | 8.7 | 62.7 | Balloon dilation | 6.6 | Survive without symptom | ||
0 | 3 | Disappear | Yes | 2.2 | 2.3 | 38.9 | 11.1 | 92.0 | Balloon dilation | 12.3 | Survive without symptom | ||
3 | 4 | Disappear | Yes | 3.2 | 5.9 | 38.6 | 12.8 | 88.2 | Balloon dilation | 17.3 | Survive without symptom | ||
0 | 0 | Decreased | No | 6.8 | 6.9 | 38.1 | 16.5 | 86.2 | PTCD | 6.9 | Died of cancer recurrence | ||
1 | 0 | Disappear | No | 1.0 | 1.0 | Normal | 3.9 | 45.4 | None | 6.8 | Survive without symptom | ||
0 | 0 | Disappear | Yes | 2.4 | 1.4 | 39.0 | 20.0 | 84.7 | None | 14.4 | Survive without symptom | ||
1 | 3 | Disappear | No | 6.0 | 2.2 | Normal | 6.0 | 85.2 | None | 6.0 | Survive without symptom | ||
0 | 4 | Disappear | Yes | 2.1 | 5.9 | 38.6 | 11.5 | 93.1 | None | 8.1 | Died of cancer recurrence | ||
0 | 0 | Decreased | No | 6.1 | 6.1 | 40.0 | 11.0 | 84.8 | None | 6.1 | Died of cancer recurrence | ||
0 | 2 | Decreased | No | 2.9 | 2.9 | 39.5 | 7.5 | 84.4 | None | 2.9 | Died of cancer recurrence | ||
0 | 2 | Decreased | Yes | 4.0 | 3.3 | Normal | 8.4 | 59.0 | None | 147.6 | Survive without symptom | ||
2 | 2 | Disappear | Yes | 8.4 | 11.4 | Normal | 17.6 | 94.2 | None | 23.9 | Survive without symptom | ||
3 | 0 | Decreased | No | 2.8 | 2.8 | Normal | 12.0 | 75.6 | None | 2.8 | Died of pulmonary infection | ||
3 | 0 | Disappear | Yes | 1.0 | 0.4 | Normal | 11.5 | 91.6 | None | 1.4 | Died of cancer recurrence | ||
0 | 2 | Disappear | No | 0.0 | 1.4 | Normal | 10.3 | 84.6 | Balloon dilation | 1.3 | Died of cancer recurrence | ||
1 | 2 | Disappear | No | 1.3 | 1.3 | 37.5 | 15.6 | 89.3 | None | 1.2 | Died of pulmonary infection | ||
2 | 3 | Decreased | No | 14.3 | 18.6 | Normal | 14.0 | 86.0 | None | 14.3 | Survive, but the fistula wasn’t healed | ||
0 | 2 | Disappear | Yes | 0.6 | 0.6 | Normal | 12.9 | 90.1 | None | 2.1 | Died of cancer recurrence | ||
0 | 6 | Disappear | Yes | 2.4 | 2.9 | Normal | 6.4 | 80.0 | Bilateral ureteral stent implantation | 7.6 | Survive without symptom | ||
1 | 0 | Disappear | Yes | 1.5 | 1.5 | 38.3 | 23.5 | 95.4 | PTCD+stenting in colon | 19.9 | Died of cancer recurrence | ||
0 | 0 | Disappear | Yes | 1.1 | 1.2 | 38.5 | 19.9 | 92.3 | None | 60.4 | Survive without symptom |